NCT04099563 Study to Assess Pharmacokinetics, Safety and Tolerability of PF-04965842 in Chinese Healthy Participants Status COMPLETED Phase PHASE1
NCT04094519 A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer Status COMPLETED Phase PHASE1
NCT04092595 A Study of PF-06651600 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants Status COMPLETED Phase PHASE1
NCT04092452 A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Status COMPLETED Phase PHASE2
NCT04091087 Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis Dermatitis Status COMPLETED Phase PHASE2
NCT04091061 Effect Of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of PF-06865571 In Subjects With Hepatic Impairment and in Healthy Subjects Status COMPLETED Phase PHASE1
NCT04090411 A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT04090047 A Study to Investigate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of PF-06700841 in Healthy Participants Status COMPLETED Phase PHASE1
NCT04084717 Study of Crizotinib for ROS1 and MET Activated Lung Cancer Status RECRUITING Phase PHASE2
NCT04079920 Predictors of Response to Tofacitinib Treatment in Rheumatoid Arthritis Patients Status COMPLETED Phase N/A
NCT04076787 Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib Status COMPLETED Phase N/A
NCT04072952 A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT04071405 Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients Status COMPLETED Phase N/A
NCT04071158 A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS Status COMPLETED Phase PHASE2
NCT04070768 Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113 Status COMPLETED Phase PHASE1
NCT04065633 Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial Formulation Status COMPLETED Phase PHASE1